Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Re-drawing the Maps for Endemic Mycoses.

Ashraf N, Kubat RC, Poplin V, Adenis AA, Denning DW, Wright L, McCotter O, Schwartz IS, Jackson BR, Chiller T, Bahr NC.

Mycopathologia. 2020 Feb 10. doi: 10.1007/s11046-020-00431-2. [Epub ahead of print] Review.

PMID:
32040709
2.

Bridging the knowledge gap on mycoses in Africa: Setting up a Pan-African Mycology Working Group.

Oladele RO, Akase IE, Fahal AH, Govender NP, Hoenigl M, Gangneux JP, Chiller TM, Denning DW, Cornely OA, Chakrabarti A.

Mycoses. 2020 Mar;63(3):244-249. doi: 10.1111/myc.13044. Epub 2019 Dec 30. Review.

PMID:
31829454
3.

Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in Botswana.

Tenforde MW, Muthoga C, Callaghan A, Ponetshego P, Ngidi J, Mine M, Jordan A, Chiller T, Larson BA, Jarvis JN.

Wellcome Open Res. 2019 Sep 25;4:144. doi: 10.12688/wellcomeopenres.15464.1. eCollection 2019.

4.

Candida auris: A Review of Recommendations for Detection and Control in Healthcare Settings.

Caceres DH, Forsberg K, Welsh RM, Sexton DJ, Lockhart SR, Jackson BR, Chiller T.

J Fungi (Basel). 2019 Nov 28;5(4). pii: E111. doi: 10.3390/jof5040111. Review.

5.

The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor - Active Surveillance in Selected Sites, United States, 2014-17.

Zhang AY, Shrum S, Williams S, Petnic S, Nadle J, Johnston H, Barter D, VonBank B, Bonner L, Hollick R, Marceaux K, Harrison L, Schaffner W, Tesini BL, Farley MM, Pierce RA, Phipps E, Mody RK, Chiller TM, Jackson BR, Vallabhaneni S.

Clin Infect Dis. 2019 Nov 2. pii: ciz1061. doi: 10.1093/cid/ciz1061. [Epub ahead of print]

PMID:
31676903
6.

Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS.

Cáceres DH, Gómez BL, Tobón AM, Chiller TM, Lindsley MD.

Mycoses. 2020 Feb;63(2):139-144. doi: 10.1111/myc.13023. Epub 2019 Nov 27.

PMID:
31625627
7.

The Diagnosis of Fungal Neglected Tropical Diseases (Fungal NTDs) and the Role of Investigation and Laboratory Tests: An Expert Consensus Report.

Hay R, Denning DW, Bonifaz A, Queiroz-Telles F, Beer K, Bustamante B, Chakrabarti A, Chavez-Lopez MG, Chiller T, Cornet M, Estrada R, Estrada-Chavez G, Fahal A, Gomez BL, Li R, Mahabeer Y, Mosam A, Soavina Ramarozatovo L, Rakoto Andrianarivelo M, Rapelanoro Rabenja F, van de Sande W, Zijlstra EE.

Trop Med Infect Dis. 2019 Sep 24;4(4). pii: E122. doi: 10.3390/tropicalmed4040122.

8.

The detection of Coccidioides from ambient air in Phoenix, Arizona: Evidence of uneven distribution and seasonality.

Gade L, McCotter OZ, Bowers JR, Waddell V, Brady S, Carvajal JA, Sunenshine R, Komatsu KK, Engelthaler DM, Chiller T, Litvintseva AP.

Med Mycol. 2019 Sep 10. pii: myz093. doi: 10.1093/mmy/myz093. [Epub ahead of print]

PMID:
31506673
9.

The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection.

Singh S, Uppuluri P, Mamouei Z, Alqarihi A, Elhassan H, French S, Lockhart SR, Chiller T, Edwards JE Jr, Ibrahim AS.

PLoS Pathog. 2019 Aug 5;15(8):e1007460. doi: 10.1371/journal.ppat.1007460. eCollection 2019 Aug.

10.

Candida auris: An Emerging Antimicrobial Resistance Threat.

Vallabhaneni S, Jackson BR, Chiller TM.

Ann Intern Med. 2019 Jul 30. doi: 10.7326/M19-2205. [Epub ahead of print] No abstract available.

PMID:
31357215
11.

Potential Fifth Clade of Candida auris, Iran, 2018.

Chow NA, de Groot T, Badali H, Abastabar M, Chiller TM, Meis JF.

Emerg Infect Dis. 2019 Sep;25(9):1780-1781. doi: 10.3201/eid2509.190686. Epub 2019 Sep 17.

12.

On the Origins of a Species: What Might Explain the Rise of Candida auris?

Jackson BR, Chow N, Forsberg K, Litvintseva AP, Lockhart SR, Welsh R, Vallabhaneni S, Chiller T.

J Fungi (Basel). 2019 Jul 6;5(3). pii: E58. doi: 10.3390/jof5030058.

13.

Hospital-Associated Multicenter Outbreak of Emerging Fungus Candida auris, Colombia, 2016.

Armstrong PA, Rivera SM, Escandon P, Caceres DH, Chow N, Stuckey MJ, Díaz J, Gomez A, Vélez N, Espinosa-Bode A, Salcedo S, Marin A, Berrio I, Varón C, Guzman A, Pérez-Franco JE, Escobar JD, Villalobos N, Correa JM, Litvintseva AP, Lockhart SR, Fagan R, Chiller TM, Jackson B, Pacheco O.

Emerg Infect Dis. 2019 Jul;25(7). doi: 10.3201/eid2507.180491.

14.

Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts' consensus recommendations.

Bongomin F, Govender NP, Chakrabarti A, Robert-Gangneux F, Boulware DR, Zafar A, Oladele RO, Richardson MD, Gangneux JP, Alastruey-Izquierdo A, Bazira J, Boyles TH, Sarcarlal J, Nacher M, Obayashi T, Worodria W, Pasqualotto AC, Meya DB, Cheng B, Sriruttan C, Muzoora C, Kambugu A, Rodriguez Tudela JL, Jordan A, Chiller TM, Denning DW.

Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1581-1584. doi: 10.1007/s10096-019-03600-4. No abstract available.

PMID:
31175479
15.

Hurricane-Associated Mold Exposures Among Patients at Risk for Invasive Mold Infections After Hurricane Harvey - Houston, Texas, 2017.

Chow NA, Toda M, Pennington AF, Anassi E, Atmar RL, Cox-Ganser JM, Da Silva J, Garcia B, Kontoyiannis DP, Ostrosky-Zeichner L, Leining LM, McCarty J, Al Mohajer M, Murthy BP, Park JH, Schulte J, Shuford JA, Skrobarcek KA, Solomon S, Strysko J, Chiller TM, Jackson BR, Chew GL, Beer KD.

MMWR Morb Mortal Wkly Rep. 2019 May 31;68(21):469-473. doi: 10.15585/mmwr.mm6821a1.

16.

Influenza Coinfection: Be(a)ware of Invasive Aspergillosis.

Verweij PE, Brüggemann RJM, Wauters J, Rijnders BJA, Chiller T, van de Veerdonk FL.

Clin Infect Dis. 2020 Jan 2;70(2):349-350. doi: 10.1093/cid/ciz391. No abstract available.

17.

Notes from the Field: Multistate Coccidioidomycosis Outbreak in U.S. Residents Returning from Community Service Trips to Baja California, Mexico - July-August 2018.

Toda M, Gonzalez FJ, Fonseca-Ford M, Franklin P, Huntington-Frazier M, Gutelius B, Kawakami V, Lunquest K, McCracken S, Moser K, Oltean H, Ratner AJ, Raybern C, Signs K, Zaldivar A, Chiller TM, Jackson BR, McCotter O.

MMWR Morb Mortal Wkly Rep. 2019 Apr 12;68(14):332-333. doi: 10.15585/mmwr.mm6814a5. No abstract available.

18.

Erratum: Candida auris: The recent emergence of a multidrug-resistant fungal Pathogen.

Forsberg K, Woodworth K, Walters M, Berkow EL, Jackson B, Chiller T, Vallabhaneni S.

Med Mycol. 2019 Jun 1;57(4):e7. doi: 10.1093/mmy/myy156. No abstract available.

PMID:
30715430
19.

Update on the Epidemiology of coccidioidomycosis in the United States.

McCotter OZ, Benedict K, Engelthaler DM, Komatsu K, Lucas KD, Mohle-Boetani JC, Oltean H, Vugia D, Chiller TM, Sondermeyer Cooksey GL, Nguyen A, Roe CC, Wheeler C, Sunenshine R.

Med Mycol. 2019 Feb 1;57(Supplement_1):S30-S40. doi: 10.1093/mmy/myy095. Review.

20.

Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.

Rajasingham R, Meya DB, Greene GS, Jordan A, Nakawuka M, Chiller TM, Boulware DR, Larson BA.

PLoS One. 2019 Jan 10;14(1):e0210105. doi: 10.1371/journal.pone.0210105. eCollection 2019.

21.

Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.

Loyse A, Burry J, Cohn J, Ford N, Chiller T, Ribeiro I, Koulla-Shiro S, Mghamba J, Ramadhani A, Nyirenda R, Aliyu SH, Wilson D, Le T, Oladele R, Lesikari S, Muzoora C, Kalata N, Temfack E, Mapoure Y, Sini V, Chanda D, Shimwela M, Lakhi S, Ngoma J, Gondwe-Chunda L, Perfect C, Shroufi A, Andrieux-Meyer I, Chan A, Schutz C, Hosseinipour M, Van der Horst C, Klausner JD, Boulware DR, Heyderman R, Lalloo D, Day J, Jarvis JN, Rodrigues M, Jaffar S, Denning D, Migone C, Doherty M, Lortholary O, Dromer F, Stack M, Molloy SF, Bicanic T, van Oosterhout J, Mwaba P, Kanyama C, Kouanfack C, Mfinanga S, Govender N, Harrison TS.

Lancet Infect Dis. 2019 Apr;19(4):e143-e147. doi: 10.1016/S1473-3099(18)30493-6. Epub 2018 Oct 18. Review.

PMID:
30344084
22.

Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey.

Chow NA, Gade L, Tsay SV, Forsberg K, Greenko JA, Southwick KL, Barrett PM, Kerins JL, Lockhart SR, Chiller TM, Litvintseva AP; US Candida auris Investigation Team.

Lancet Infect Dis. 2018 Dec;18(12):1377-1384. doi: 10.1016/S1473-3099(18)30597-8. Epub 2018 Oct 4.

23.

Multidrug-Resistant Aspergillus fumigatus Carrying Mutations Linked to Environmental Fungicide Exposure - Three States, 2010-2017.

Beer KD, Farnon EC, Jain S, Jamerson C, Lineberger S, Miller J, Berkow EL, Lockhart SR, Chiller T, Jackson BR.

MMWR Morb Mortal Wkly Rep. 2018 Sep 28;67(38):1064-1067. doi: 10.15585/mmwr.mm6738a5.

24.

Estimation of Direct Healthcare Costs of Fungal Diseases in the United States.

Benedict K, Jackson BR, Chiller T, Beer KD.

Clin Infect Dis. 2019 May 17;68(11):1791-1797. doi: 10.1093/cid/ciy776.

PMID:
30204844
25.

Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study.

Adenis AA, Valdes A, Cropet C, McCotter OZ, Derado G, Couppie P, Chiller T, Nacher M.

Lancet Infect Dis. 2018 Oct;18(10):1150-1159. doi: 10.1016/S1473-3099(18)30354-2. Epub 2018 Aug 23.

26.

Risk Stratification With Coccidioidal Skin Test to Prevent Valley Fever Among Inmates, California, 2015.

Wheeler C, Lucas KD, Derado G, McCotter O, Tharratt RS, Chiller T, Mohle-Boetani JC.

J Correct Health Care. 2018 Oct;24(4):342-351. doi: 10.1177/1078345818792679. Epub 2018 Aug 13.

27.

Candida auris: The recent emergence of a multidrug-resistant fungal pathogen.

Forsberg K, Woodworth K, Walters M, Berkow EL, Jackson B, Chiller T, Vallabhaneni S.

Med Mycol. 2019 Jan 1;57(1):1-12. doi: 10.1093/mmy/myy054. Review. Erratum in: Med Mycol. 2019 Jun 1;57(4):e7.

PMID:
30085270
28.

Interlaboratory agreement of coccidioidomycosis enzyme immunoassay from two different manufacturers.

Khan S, Saubolle MA, Oubsuntia T, Heidari A, Barbian K, Goodin K, Eguchi M, McCotter OZ, Komatsu K, Park BJ, Geiger MC, Mohamed A, Chiller T, Sunenshine RH.

Med Mycol. 2019 Jun 1;57(4):441-446. doi: 10.1093/mmy/myy059.

PMID:
30085141
29.

Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance.

Escandón P, Chow NA, Caceres DH, Gade L, Berkow EL, Armstrong P, Rivera S, Misas E, Duarte C, Moulton-Meissner H, Welsh RM, Parra C, Pescador LA, Villalobos N, Salcedo S, Berrio I, Varón C, Espinosa-Bode A, Lockhart SR, Jackson BR, Litvintseva AP, Beltran M, Chiller TM.

Clin Infect Dis. 2019 Jan 1;68(1):15-21. doi: 10.1093/cid/ciy411.

PMID:
29788045
30.

Emerging Multidrug-Resistant Candida duobushaemulonii Infections in Panama Hospitals: Importance of Laboratory Surveillance and Accurate Identification.

Ramos R, Caceres DH, Perez M, Garcia N, Castillo W, Santiago E, Borace J, Lockhart SR, Berkow EL, Hayer L, Espinosa-Bode A, Moreno J, Jackson BR, Moran J, Chiller T, de Villarreal G, Sosa N; Red Nacional de Vigilancia Epidemiologica en Microbiologia Clinica, Vallabhaneni S.

J Clin Microbiol. 2018 Jun 25;56(7). pii: e00371-18. doi: 10.1128/JCM.00371-18. Print 2018 Jul.

31.

Notes from the Field: Surveillance for Candida auris - Colombia, September 2016-May 2017.

Escandón P, Cáceres DH, Espinosa-Bode A, Rivera S, Armstrong P, Vallabhaneni S, Berkow EL, Lockhart SR, Chiller T, Jackson BR, Duarte C.

MMWR Morb Mortal Wkly Rep. 2018 Apr 20;67(15):459-460. doi: 10.15585/mmwr.mm6715a6. No abstract available.

32.

Multicenter Validation of Commercial Antigenuria Reagents To Diagnose Progressive Disseminated Histoplasmosis in People Living with HIV/AIDS in Two Latin American Countries.

Cáceres DH, Samayoa BE, Medina NG, Tobón AM, Guzmán BJ, Mercado D, Restrepo A, Chiller T, Arathoon EE, Gómez BL.

J Clin Microbiol. 2018 May 25;56(6). pii: e01959-17. doi: 10.1128/JCM.01959-17. Print 2018 Jun.

33.

Neonatal and Pediatric Candidemia: Results From Population-Based Active Laboratory Surveillance in Four US Locations, 2009-2015.

Benedict K, Roy M, Kabbani S, Anderson EJ, Farley MM, Harb S, Harrison LH, Bonner L, Wadu VL, Marceaux K, Hollick R, Beldavs ZG, Zhang AY, Schaffner W, Graber CR, Derado G, Chiller TM, Lockhart SR, Vallabhaneni S.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):e78-e85. doi: 10.1093/jpids/piy009.

PMID:
29522195
34.

CD4 Cell Count Threshold for Cryptococcal Antigen Screening of HIV-Infected Individuals: A Systematic Review and Meta-analysis.

Ford N, Shubber Z, Jarvis JN, Chiller T, Greene G, Migone C, Vitoria M, Doherty M, Meintjes G.

Clin Infect Dis. 2018 Mar 4;66(suppl_2):S152-S159. doi: 10.1093/cid/cix1143.

35.

Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi-year, multicenter prospective cohort study.

Avery RK, Silveira FP, Benedict K, Cleveland AA, Kauffman CA, Schuster MG, Dubberke ER, Husain S, Paterson DL, Chiller T, Pappas P.

Transpl Infect Dis. 2018 Jun;20(3):e12877. doi: 10.1111/tid.12877. Epub 2018 Mar 30.

36.

Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients.

Dubberke ER, Reske KA, Olsen MA, Bommarito K, Cleveland AA, Silveira FP, Schuster MG, Kauffman CA, Avery RK, Pappas PG, Chiller TM.

Transpl Infect Dis. 2018 Apr;20(2):e12855. doi: 10.1111/tid.12855. Epub 2018 Mar 6.

37.

The important role of co-infections in patients with AIDS and progressive disseminated histoplasmosis (PDH): A cohort from Colombia.

Caceres DH, Tobón ÁM, Restrepo Á, Chiller T, Gómez BL.

Med Mycol Case Rep. 2018 Jan 17;19:41-44. doi: 10.1016/j.mmcr.2017.07.004. eCollection 2018 Mar.

38.

Dating the Cryptococcus gattii Dispersal to the North American Pacific Northwest.

Roe CC, Bowers J, Oltean H, DeBess E, Dufresne PJ, McBurney S, Overy DP, Wanke B, Lysen C, Chiller T, Meyer W, Thompson GR 3rd, Lockhart SR, Hepp CM, Engelthaler DM.

mSphere. 2018 Jan 17;3(1). pii: e00499-17. doi: 10.1128/mSphere.00499-17. eCollection 2018 Jan-Feb.

39.

Standardization and validation of real time PCR assays for the diagnosis of histoplasmosis using three molecular targets in an animal model.

López LF, Muñoz CO, Cáceres DH, Tobón ÁM, Loparev V, Clay O, Chiller T, Litvintseva A, Gade L, González Á, Gómez BL.

PLoS One. 2017 Dec 29;12(12):e0190311. doi: 10.1371/journal.pone.0190311. eCollection 2017.

40.

Evaluation of a Cryptococcal antigen Lateral Flow Assay in serum and cerebrospinal fluid for rapid diagnosis of cryptococcosis in Colombia.

Cáceres DH, Zuluaga A, Tabares ÁM, Chiller T, González Á, Gómez BL.

Rev Inst Med Trop Sao Paulo. 2017 Dec 21;59:e76. doi: 10.1590/S1678-9946201759076.

41.

Recognition of Azole-Resistant Aspergillosis by Physicians Specializing in Infectious Diseases, United States.

Walker TA, Lockhart SR, Beekmann SE, Polgreen PM, Santibanez S, Mody RK, Beer KD, Chiller TM, Jackson BR.

Emerg Infect Dis. 2018 Jan;24(1). doi: 10.3201/eid2401.170971.

42.

Outbreak of Severe Histoplasmosis Among Tunnel Workers-Dominican Republic, 2015.

Armstrong PA, Beard JD, Bonilla L, Arboleda N, Lindsley MD, Chae SR, Castillo D, Nuñez R, Chiller T, de Perio MA, Pimentel R, Vallabhaneni S.

Clin Infect Dis. 2018 May 2;66(10):1550-1557. doi: 10.1093/cid/cix1067.

PMID:
29211836
43.

Management of an Outbreak of Exophiala dermatitidis Bloodstream Infections at an Outpatient Oncology Clinic.

Vasquez A, Zavasky D, Chow NA, Gade L, Zlatanic E, Elkind S, Litvintseva AP, Pappas PG, Perfect JR, Revankar S, Lockhart SR, Chiller T, Ackelsberg J, Vallabhaneni S.

Clin Infect Dis. 2018 Mar 5;66(6):959-962. doi: 10.1093/cid/cix948.

PMID:
29121235
44.

High Cryptococcal Antigen Titers in Blood Are Predictive of Subclinical Cryptococcal Meningitis Among Human Immunodeficiency Virus-Infected Patients.

Wake RM, Britz E, Sriruttan C, Rukasha I, Omar T, Spencer DC, Nel JS, Mashamaite S, Adelekan A, Chiller TM, Jarvis JN, Harrison TS, Govender NP.

Clin Infect Dis. 2018 Feb 10;66(5):686-692. doi: 10.1093/cid/cix872.

45.

Approach to the Investigation and Management of Patients With Candida auris, an Emerging Multidrug-Resistant Yeast.

Tsay S, Kallen A, Jackson BR, Chiller TM, Vallabhaneni S.

Clin Infect Dis. 2018 Jan 6;66(2):306-311. doi: 10.1093/cid/cix744. Review.

46.

Isolation of Candida auris from 9 patients in Central America: Importance of accurate diagnosis and susceptibility testing.

Araúz AB, Caceres DH, Santiago E, Armstrong P, Arosemena S, Ramos C, Espinosa-Bode A, Borace J, Hayer L, Cedeño I, Jackson BR, Sosa N, Berkow EL, Lockhart SR, Rodriguez-French A, Chiller T.

Mycoses. 2018 Jan;61(1):44-47. doi: 10.1111/myc.12709. Epub 2017 Oct 16.

PMID:
28945325
47.

Thinking beyond the Common Candida Species: Need for Species-Level Identification of Candida Due to the Emergence of Multidrug-Resistant Candida auris.

Lockhart SR, Jackson BR, Vallabhaneni S, Ostrosky-Zeichner L, Pappas PG, Chiller T.

J Clin Microbiol. 2017 Dec;55(12):3324-3327. doi: 10.1128/JCM.01355-17. Epub 2017 Sep 13.

48.

Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: A feasibility study in rural Lesotho.

Rick F, Niyibizi AA, Shroufi A, Onami K, Steele SJ, Kuleile M, Muleya I, Chiller T, Walker T, Van Cutsem G.

PLoS One. 2017 Sep 6;12(9):e0183656. doi: 10.1371/journal.pone.0183656. eCollection 2017.

49.

Emerging issues, challenges, and changing epidemiology of fungal disease outbreaks.

Benedict K, Richardson M, Vallabhaneni S, Jackson BR, Chiller T.

Lancet Infect Dis. 2017 Dec;17(12):e403-e411. doi: 10.1016/S1473-3099(17)30443-7. Epub 2017 Jul 31. Review.

50.

Neglected endemic mycoses.

Queiroz-Telles F, Fahal AH, Falci DR, Caceres DH, Chiller T, Pasqualotto AC.

Lancet Infect Dis. 2017 Nov;17(11):e367-e377. doi: 10.1016/S1473-3099(17)30306-7. Epub 2017 Jul 31. Review.

PMID:
28774696

Supplemental Content

Loading ...
Support Center